U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07419724) titled 'Construction of a Portal Hypertension Biobank' on Feb. 12.
Brief Summary: Esophageal and gastric variceal bleeding (EGVB) is a severe complication of portal hypertension (PH), characterized by high bleeding volume, high rebleeding rate, and high mortality. In recent years, endoscopic treatment has significantly improved therapeutic efficacy and patient survival. However, due to substantial individual variations among patients, individualized stratified management is crucial. For special populations with cirrhotic portal hypertension, clear management guidelines and clinical research evidence are lacking. The incidence of non-cirrhot...